Moreover, the BAPTA-AM intracellular Ca2+ chelator could inhibit the expression of all MDR-related mechanisms, suggesting that TRPC6 is responsible for Ca2+-dependent MDR in HCC [35]. The gene discussed is TRPC6; the disease is hepatocellular carcinoma.